Kaftrio for Cystic Fibrosis

Kaftrio for Cystic Fibrosis

Kaftrio is a fixed-dose triple combination therapy containing elexacaftor, tezacaftor, and ivacaftor, used in the treatment of cystic fibrosis (CF). Clinical trial results have been excellent, and the drug has been hailed as a revolutionary innovation in CF management.